Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;18(6):377-83.
doi: 10.5114/wo.2014.45111. Epub 2014 Oct 16.

Are we a step forward with targeted agents in resolving the enigma of mantle cell lymphoma?

Ivan Petković  1 , Ivica Pejčić  2 , Svetislav Vrbić  2
Affiliations
Review

Are we a step forward with targeted agents in resolving the enigma of mantle cell lymphoma?

Ivan Petković et al. Contemp Oncol (Pozn). 2014.

Abstract

Mantle cell lymphoma has been recognized as a distinct entity from the other non-Hodgkin lymphomas in middle 1990's. It carries a worst prognosis among all mature B-cell malignancies. Cyclin D1 and recently SOX11 are the hallmarks for this disease. Even if it is highly responsive to induction treatment, it remains incurable, since it inevitably relapses. Highly aggressive approaches with stem cell transplantation can shift the survival curve for a bit, but even so the overall survival is not significantly improved in most of the cases. Small portion of patients with this heterogeneous disease have an indolent course with long-term survival. Conventional immunochemotherapy has reached its maximal possibilities, so novel target agents are absolutely warranted. The large number of ongoing early phase trials demonstrated promising results, especially emphasizing agents that target B-cell receptor. They are mostly investigated in relapsed/refractory disease, while front-line approaches with those agents need to be explored in future times.

Keywords: immunochemotherapy; mantle cell lymphoma; stem cell transplantation; targeted agents.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–92. - PubMed
    1. Smedby KE, Hjalgrim H. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol. 2011;21:293–8. - PubMed
    1. Trozzi PL, Borowitz MJ, Gockerman JP. Gastrointestinal involvement and multiple lymphomatous polyposis in mantle-zone lymphoma. J Clin Oncol. 1986;4:866–73. - PubMed
    1. Petković I, Mihailović D, Krstić M, et al. Primary mantle cell lymphoma of gastrointestinal tract – a case report. Acta Medica Medianae. 2012;51:41–6.
    1. Dreyling M, Kluin-Nelemans HC, Beà S, et al. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th Annual Conference of the European Mantle Cell Lymphoma Network. Leuk Lymphoma. 2013;54:699–707. - PubMed

LinkOut - more resources